| Primary |
| Osteomyelitis |
20.8% |
| Drug Use For Unknown Indication |
8.3% |
| Herpes Zoster |
8.3% |
| Hypertension |
8.3% |
| Pain |
8.3% |
| Post Procedural Infection |
8.3% |
| Skin Infection |
8.3% |
| Staphylococcal Infection |
8.3% |
| Abscess |
4.2% |
| Analgesia |
4.2% |
| Deep Vein Thrombosis |
4.2% |
| Hypercholesterolaemia |
4.2% |
| Procedural Pain |
4.2% |
|
| Rhabdomyolysis |
30.0% |
| Respiratory Distress |
20.0% |
| Acute Hepatic Failure |
10.0% |
| Agranulocytosis |
10.0% |
| Jaundice |
10.0% |
| Melaena |
10.0% |
| Subdural Haematoma |
10.0% |
|
| Secondary |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
13.8% |
| Sinus Disorder |
12.1% |
| Sepsis |
8.4% |
| Infection |
4.2% |
| Pyrexia |
3.5% |
| Cellulitis |
3.2% |
| Colon Cancer |
3.2% |
| Epilepsy |
3.2% |
| Osteomyelitis |
3.2% |
| Cough |
3.0% |
| Multiple Myeloma |
3.0% |
| Pseudomonas Infection |
3.0% |
| Arthritis Bacterial |
2.7% |
| Staphylococcal Infection |
2.7% |
| Decubitus Ulcer |
2.5% |
| Liver Abscess |
2.5% |
| Acute Leukaemia |
2.2% |
| Depression |
2.2% |
| Pain |
2.2% |
|
| Metabolic Acidosis |
15.5% |
| Pyroglutamate Increased |
9.5% |
| Rhabdomyolysis |
8.3% |
| Vomiting |
7.1% |
| Renal Failure Acute |
6.0% |
| Agranulocytosis |
4.8% |
| Anaphylactic Reaction |
4.8% |
| Dermatitis Exfoliative |
4.8% |
| Vision Blurred |
4.8% |
| Diarrhoea |
3.6% |
| Sepsis |
3.6% |
| Splenic Infarction |
3.6% |
| Stress Cardiomyopathy |
3.6% |
| Thrombocytopenia |
3.6% |
| Wheezing |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Abdominal Pain Upper |
2.4% |
| Cholestasis |
2.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.4% |
| Encephalopathy |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.3% |
| Drug Use For Unknown Indication |
12.8% |
| Rheumatoid Arthritis |
5.0% |
| Osteomyelitis |
4.8% |
| Multiple Myeloma |
3.8% |
| Malnutrition |
3.5% |
| Arthritis Bacterial |
3.3% |
| Prophylaxis |
3.3% |
| Infection |
2.9% |
| Pain |
2.7% |
| Hypertension |
2.4% |
| Depression |
2.1% |
| Diabetes Mellitus |
1.9% |
| Diabetic Foot |
1.9% |
| Hepatic Function Abnormal |
1.9% |
| Urethritis |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Localised Infection |
1.5% |
| Staphylococcal Infection |
1.4% |
| Hepatic Neoplasm Malignant |
1.3% |
|
| Rhabdomyolysis |
25.0% |
| Distal Intestinal Obstruction Syndrome |
7.5% |
| Drug Interaction |
6.9% |
| Diarrhoea |
5.6% |
| Renal Failure Acute |
5.0% |
| Blood Bilirubin Increased |
4.4% |
| Erectile Dysfunction |
4.4% |
| Renal Impairment |
4.4% |
| Sepsis |
3.8% |
| Vomiting |
3.8% |
| Malaise |
3.1% |
| Neutropenia |
3.1% |
| Pseudoporphyria |
3.1% |
| Rash |
3.1% |
| Renal Tubular Necrosis |
3.1% |
| Thrombocytopenia |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Abasia |
2.5% |
| Balanitis |
2.5% |
| Dyspnoea |
2.5% |
|
| Interacting |
| Sepsis |
25.9% |
| Epilepsy |
15.5% |
| Joint Arthroplasty |
10.3% |
| Staphylococcal Infection |
10.3% |
| Product Used For Unknown Indication |
8.6% |
| Arthralgia |
6.9% |
| Procedural Pain |
6.9% |
| Staphylococcal Sepsis |
6.9% |
| Wound Complication |
5.2% |
| Analgesia |
1.7% |
| Arthritis Bacterial |
1.7% |
|
| Pyroglutamate Increased |
58.8% |
| Drug Interaction |
11.8% |
| Metabolic Acidosis |
11.8% |
| Confusional State |
5.9% |
| Incoherent |
5.9% |
| Rhabdomyolysis |
5.9% |
|
